Jump to content

How To Invest In Legalized Marijuana


washtenaut

Recommended Posts

Remember in the movie 'The Graduate' when Dustin met that guy at the party that said something like, 'I just want to say one word to you - just one word - 'plastics' ?

 

Well, today, here's one word of advice for investors....cannabis. People will laugh, like they did at plastics, and it's tough to pick exactly who the winners will be but it sure seems like a budding industry. Yes, pun intended.

 

Here's an interesting article on a few companies and angles:

 

 

How to invest in legalized marijuana

 

Mark Twain is said to have remarked that a gold rush is a good time to be in the pick and shovel business. Investors may be able to apply that same bit of wisdom to the growing number of U.S. states that have legalized pot.

 

Although federal law prohibits the sale or possession of marijuana, Massachusetts last week joined the ranks of states — 18 plus Washington, D.C. — that allow....... (see link below)

 

 

Link to comment
Share on other sites

  • 2 weeks later...

GW Pharmaceuticals today released preliminary financial results for 2012 along with some Research and Development information...here is a link to the webcast.

 

Lol...as with a lot of these webcasts of financial results, its hard to tell whether to buy or sell. Also, Otsuka ....will they benefit more than GW if the US gives approval?

 

https://arkadin-trial.webex.com/arka...FBCF224CD40A62

Link to comment
Share on other sites

  • 2 weeks later...

leaving your stock with your broker might help. Once its in your hands, its tough not to just burn thru it....lol

 

I saw that tonight on Fox News, yes even Fox News, there will be a cannabis business segment by Geraldo Rivera. Company MJNA owns Dixie Elixirs.

 

Medical Marijuana Inc. and the Dixie Elixirs and Edibles Brand will be on Fox News Geraldo at Large on December 8, 2012.

12/07/2012 @ 2:09PM

 

 

SAN DIEGO, Dec. 7, 2012 /PRNewswire/ -- Medical Marijuana Inc. (OTC: MJNA), a leading hemp industry innovator, is pleased to announce that its portfolio company, Red Dice Holdings, continues to receive national media attention for its Dixie Elixirs & Edibles brand on the CNN "Washington State's New Pot Law Takes Effect." segmentyesterday, December 6th.

Tripp Keber, President and CEOicon1.png of Red Dice Holdings LLC, was interviewed yesterday by Brooke Baldwin on CNN News Room regarding the passage of several key marijuana legalization initiatives in Washington and Colorado and expansion plans for those markets. The interview can be heard at http://newsroom.blogs.cnn.com/2012/12/06/washington-states-new-pot-law-takes-effect/

Mr. Keber will also be featured on Fox News' Geraldo Rivera on Saturday night regarding legalization of marijuana as a milestone to end prohibition. To view that interview: http://www.foxnews.com/on-air/geraldo/index.html

Also, Ted Caligiuri, Interim President of Medical Marijuana Inc. discusses the company's recently released Q3 financials in a new audio interview at SmallCapVoice.com. The interview can be heard at http://smallcapvoice.com/blog/12-4-12-smallcapvoice-interview-with-medical-marijuana-inc-mjna

 

During the interview Mr. Caligiuri also discusses the exciting growth in the entire medical marijuana market, the new markets the Company is exploring, the goals for MJNA in 2013, an update on the up listing efforts by the company and much more.

About Medical Marijuana, Inc.

Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally friendly, economically sustainable businesses, while increasing shareholder valueicon1.png.

Medical Marijuana Inc. does not grow, sell or distribute any substances that violate United States Law or the controlled substance act.

For more information, please visiticon1.png the company's website at:

www.MedicalMarijuanaInc.com

 

FORWARD-LOOKING DISCLAIMER

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchangeicon1.png Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financialicon1.png results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.

FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE

These statements have not been evaluated by the Food and Drug Administration (FDA). These products and statements are not intended to diagnose, treat, cure, or prevent any disease.

Corporate Contact:

Medical Marijuana, Inc.

Toll Free: 888-OTC-MJNA (888-682-6562)

www.medicalmarijuanainc.com

www.facebook.com/mjnainc

Investor Relations Contact:

Stuart T. Smith

SmallCapVoice.Com, Inc.

P. 512-267-2430

F. 512-267-2530

Email: ssmith@smallcapvoice.com

Skype: SmallCapVoice.com

AIM: SmallCapVoice7

SOURCE Medical Marijuana Inc. rt.gif?NewsItemId=NE26194&Transmission_Id=201212071409PR_NEWS_USPR_____NE26194&DateId=20121207

Copyright 2012 PR Newswire

Link to comment
Share on other sites

I found this collection of links for company MJNA, the parent company of Dixie Elixirs. PBS' Nightly Business Report did a report on MJNA last night with a follow-up due this evening.

 

***** $MJNA PRESS STICKY BOMB*******

 

PBS Nightly Business Report: The Legal Fate of Legalized Marijuana in Colorado & Washington | Dec 12, 2012 - NBR | Nightly Business Report

Marketwatch: How to invest in legalized marijuana - MarketWatch

NPR (Go to 29:45 minute mark): NPR Media Player

CBS 60 Minutes: Medical Marijuana: Will Colorado's "green rush" last? - 60 Minutes - CBS News

CBS 60 Minutes Overtime: Marijuana like you've never seen it before - 60 Minutes Overtime - CBS News

Newsweek Cover Story: Will Pot Barons Cash In on Legalization? - Newsweek and The Daily Beast

CNN:

Barron's: Medical Marijuana Stock Could Reach New Highs on Ballot Approvals - Stocks To Watch Today - Barrons.com

Fox News:

The Associated Press:

KTVB: Medical marijuana businesses thrive under Colorado's tough rules | KTVB.COM Boise

Link to comment
Share on other sites

  • 1 month later...

Medical Marijuana Inc. Swings to $3.4 Million Profit in Q4 on Expansion, National Exposure

Tags: canchew, cannabis stocks, medical marijuana inc. dixie elixirs, phytosphere

 

California-based Medical Marijuana Inc. closed out 2012 on a high note, reporting a record $3.4 million profit in the fourth quarter as it continued to gain traction in the edibles and hemp markets.

 

The company – which trades on the over-the-counter market under the symbol MJNA – posted a $62,711 loss for the same period in 2011. Its revenues rose nearly twelvefold from a year earlier to hit a new quarterly high of $5.10 million for the last three months of 2012.

 

The whole industry should eye Medical Marijuana Inc. and other publicly traded MMJ companies closely, as they can serve as a barometer of how the investment community feels about cannabis opportunities in general. Many medical cannabis and hemp stocks, for example, soared after Colorado and Washington legalized marijuana for recreational use as optimism rose among investors.

 

The industry also needs a handful of strong, stable and credible publicly traded companies to highlight the potential of the medical marijuana business. Most publicly traded cannabis companies trade on the over-the-counter (OTC) market and are classified as “penny stocks,” which are subject to extreme volatility and are viewed as highly risky investments.

 

Medical Marijuana Inc. falls into that category but is hoping to gain more credibility with investors, possibly by moving from the OTC market to a more reputable stock exchange. It has hired an accounting firm to officially audit its quarterly financial documents for the past two years. Such audits are required each quarter on exchanges like the Nasdaq but are not mandatory on the over-the-counter market.

 

“The audit process is crucial to our up-listing plans as well as to provide our shareholders confidence in our financial reporting,” Michelle Sides, chairman of Medical Marijuana Inc., said in a release. “We are obviously pleased with our Q4 results, but are even more excited about the opportunity for MJNA in this ever-growing industry.”

 

Medical Marijuana Inc. owns several companies involved in the medical cannabis industry, including the biotech/cultivation firm PhytoSphere and Red Dice Holdings, which runs infused products maker Dixie Elixirs & Edibles. Its portfolio of businesses also includes several firms focused on hemp-based products, such as CanChew Bio-Technologies and HempMeds RX.

 

Medical Marijuana Inc. reported several milestones in the fourth quarter that helped fuel revenues.

 

Among the biggest:

 

- Dixie Elixirs, which is quickly becoming its flagship company, continued to expand aggressively across the country, developing wholesale partnerships in Arizona, California, New Mexico and Washington. It also received national media exposure, appearing on “60 Minutes,” CNN and PBS.

 

- PhytoSphere Systems boosted production of hemp cannabidiol (CBD) oil for Medical Marijuana Inc.’s products and third-party sales by 50% on a quarter-to-quarter basis.

 

Aside from revenue-generating moves, Medical Marijuana Inc. also invested in the future and laid the groundwork to expand internationally, finalizing plans for European clinical trials of CanChew and agreeing to pump $4.7 million into the effort.

 

The company’s stock rose 25% on the financial results, hitting 15 cents a share. It has settled down a bit this morning and is trading at about 14 cents. A year ago, Medical Marijuana Inc. was trading at just 3 cents.

 

http://mmjbusinessdaily.com/2013/01/23/medical-marijuana-inc-swings-to-3-4-million-profit-in-q4-on-expansion-national-exposure/

Link to comment
Share on other sites

Anyone else paying any attention to this breakout in the cannabis stocks?

 

As of 11:25am today.

 

Recall that prices change rapidly...

 

Buyer beware!!!!

 

GRNH going wild...up over 50% today

 

HEMP up over 30% today

 

MJNA still moving up. It is over $0.43 - up over 40% again today. This time of day has been when it seems to fade a bit.

 

CBIS moving up too - about 25%.

 

RFMK treading water to up slightly.

 

GWPRF falling again - down 7%.

 

 

Cannabis Industry Impact: Economists Believe Ending Marijuana Prohibition Could Save The U.S. Nearly $14 Billion Annually

Article from Friday, 2/1/2013...I think..or the day before

 

The Bull in Advantage Network presents the following list of OTC stocks in the cannabis industry, or related fields. We recognize that America is at the beginning of a "Green Rush", an ever-increasing interest in the rapidly growing industry surrounding what seems to be the beginning of the end of marijuana prohibition on a widespread scale. There are now 18 states that permit medical marijuana for people suffering from a multitude of serious illnesses and disorders, while voters in Washington and Colorado have already crossed the plane into legalization of recreational use. According to a paper published in 2012 and endorsed by 300 economists, ending marijuana prohibition enforcement on a federal level and placing taxes on the substance similar to those placed on tobacco, could save the US over $13.5 billion annually.

 

The stocks featured in today's report are all marijuana-related, and first began to appear in our newsletters and blog as part of a special Medical Marijuana Round-Up Report on October 16th. Due to the extreme success of the plays mentioned, we have released several follow-up reports since that time. Copies of these reports may be found on our blog at Blue Horseshoe Stocks - Penny Stocks - Newsletter - Blog. Each of these stocks has gained at least 25% in early morning trading today: Cannabis Science, Inc. (OTCQB:CBIS), Medical Marijuana Inc. (OTC pink:MJNA), Hemp, Inc. (OTC pink:HEMP), X-Change Corp (The) (OTCQB:XCHC), & GreenGro Technologies, Inc.(OTC pink:GRNH).

 

Cannabis Science, Inc. (OTCQB:CBIS) is in the Research & Development of medical cannabis compounds and products. This Morning's Trading Range: .0581-.0749 | Possible Gain: 29%

 

Medical Marijuana Inc. (OTC pink:MJNA) is vested in the medical marijuana and industrial hemp markets. The company is comprised of a diversified portfolio of products, services, technology and businesses solely focused on the cannabis and hemp industries. This Morning's Trading Range: .247-.35 | Possible Gain: 42%

 

Hemp, Inc. (OTC pink:HEMP) focuses on the vast market created by the quickly emerging, and growing, multibillion dollar industrial hemp industry. This Morning's Trading Range: .0362-.049 | Possible Gain: 25%

 

X-Change Corp (The) (OTCQB:XCHC) is a company whose niche is extract-based cosmeceutical and nutraceutical solutions through its Phytiva brand product line, recently acquired from Cannabis Science, Inc. This Morning's Trading Range: .0745-.11 | Possible Gain: 48%

 

GreenGro Technologies, Inc.(OTC pink:GRNH) provides green technologies in indoor and outdoor agricultural science systems serving both the consumer and commercial farming markets. Its customers include restaurants, community gardens, small and large scale commercial clients. This Morning's Trading Range: .044-.064 | Possible Gain: 45%

 

For updates and coverage on these and other promising stocks, subscribe at Bull In Advantage | Stock Alerts, or visit our blog at Blue Horseshoe Stocks - Penny Stocks - Newsletter - Blog.

 

About Bull in Advantage:

 

For over 10 years, the Bull in Advantage Network has been working tirelessly to provide the public with the #1 stock newsletters available.

 

We scan thousands of stocks daily to find the very best 52-week low bounce-plays, high-volume momentum movers, and promising start-ups with unique business models. We also cover big board sectors and blue-chip stocks along with related options trading ideas. We gather information on all of the best opportunities, and pass it along to our readers.

 

What sets us apart from so many competitors is our coverage of multiple symbols each day. We strive to provide a diverse array of selections with real potential, and present them in a very straightforward manner. Sign up for our free newsletter today, and welcome to the Bull in Advantage family!

 

Sign up is always free at: Bull In Advantage | Stock Alerts

 

Disclaimer:

 

The assembled information disseminated by Bull in Advantage is for informative purposes only, and is neither a solicitation to buy nor an offer to sell securities. Bull in Advantage LLC owners/operators are not licensed financial advisors or analysts in any jurisdiction whatsoever. Always do your own due diligence, and consult a financial advisor before making any investment. Full compensatory disclosure is available at Disclaimer | Bull In Advantage

 

Contact:Bull in Advantage LLCEmail: info@bullinadvantage.comPhone: (561) 228-1692

Link to comment
Share on other sites

mjna has been on a nice roll lately. Seems to be run more like a business than some of the others too.

 

They are in the process of gettng the last 24 months of financial statements audited. I think by 2/15 they are supposed to release the results. I understand that they are doing this so that they can move closer toward nasdaq listing

Link to comment
Share on other sites

Here's a new article on the subject....

 

5 Marijuana Stocks Going Crazy (And This Could Be Just The Beginning) - Seeking Alpha

 

5 Marijuana Stocks Going Crazy (And This Could Be Just The Beginning)

February 5, 2013 | includes: CBIS.OB, GRNH.PK, HEMP.PK, MJNA.PK, PHOT.OB

 

Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. (More...)

 

Marijuana stocks could be absolutely huge in 2013, as efforts to legalize the drug in more states continue. Already, marijuana possession and recreational use has been made legal in two states (Colorado and Washington) since the beginning of November 2012, and numerous senators, organizations and voters in many other states are also strongly in favor of the legalization of marijuana. In this article I'll highlight a few marijuana-related stocks that have already made big moves, and could be set for huge bull runs in future.

 

Marijuana Legalization By State

 

A Quinnipiac University poll found that a majority of those surveyed support the legalization of marijuana, as do I. Studies show that marijuana is a harmless, safe drug that has few (if any) negative side effects. It certainly can be argued that recreational use of marijuana is far less harmful than regularly drinking alcohol. Numerous politicians and presidents, including Barack Obama, George Bush, Sarah Palin, George Washington and others, have (or had) admitted to smoking pot. It seems nonsensical to imprison people for smoking pot, waste millions of dollars in taxpayer money, and create a black market for marijuana by making it illegal.

 

There are numerous small-cap, very volatile marijuana stocks that have been making moves lately that you cannot afford to ignore if you are interested in profiting off this industry. The 5 most interesting I have identified are Medical Marijuana Inc (MJNA.PK), HEMP INC (HEMP.PK), Cannabis Science Inc (CBIS.OB), Growlife Inc (PHOT.OB) and GreenGro Technologies (GRNH.PK). On Friday 1st February 2013, every one of these stocks began to make huge moves of between 20% and 40% upwards, and continued running the following week. Many also have very low market caps, meaning they can very easily spike higher. Another state legalizing marijuana use, or some more press releases, and all these stocks could go on further runs upwards very easily.

 

While there is huge upside potential, it must be stressed that these stocks are all risky, and very volatile. Most of them have very bad fundamentals, and there is a high element of risk in playing these stocks especially if you're not a full time trader. If you do trade any of these stocks, I recommend keeping position sizes small, and cutting any losses quickly.

 

What follows is a summary of each marijuana stock, starting with the main one, MJNA.

 

Speculative Marijuana Stock #1: Medical Marijuana Inc

 

With a current market cap of around $300 million (fluctuating wildly as the stock moves up and down), MJNA is the biggest of the marijuana stocks currently in play. It claims to be the first publicly traded company vested in medical marijuana, and offers a variety of products and services related to marijuana and hemp. In its portfolio, it lists five featured companies under its control: Phytosphere Systems, Red Dice Holdings, HempMeds, Wellness Managed Services and Can Chew Bio Technologies.

 

On January 22nd 2013, MJNA reported strong earnings for its fourth quarter of 2012, with net income of $3.39 million on gross revenues of $5.10 million, representing a 1,100% increase in revenues over the same quarter of 2011. MJNA's most recent earnings and financial statements will be audited by the accounting firm Anthony W. Imbimbo & Associates by mid February. Curiously, MJNA did not spike up and go on a strong bull run upon announcing its strong Q4 2012 earnings; this only really began on Friday 1st February when there was no apparent news.

 

MJNA could be set for stronger gains and is certainly a very dangerous stock to consider shorting, even having gone on a big run upwards. The time to buy this stock could be on breakouts to new highs, on strong volume, or when positive press releases or news is released. MJNA could also be invested in for the long term, for those who have a high risk tolerance and are not afraid of volatility.

 

Speculative Marijuana Stock #2: HEMP, INC

 

HEMP has 1,121,640,756 outstanding shares, giving it a very rough market cap of around $50 million at its current price. HEMP has a slightly different primary focus to the other marijuana stocks (hemp and marijuana are different varieties of the same species of plant) but is very clearly following the same path as marijuana stocks, and will very likely still benefit from marijuana legalization. It had previously spiked up a huge amount in late 2012, before coming back down and then running up again recently.

 

HEMP has numerous subsidiaries, such as Marijuana Inc. (aimed at offering HEMP solutions and educating the public on the benefits of HEMP), Marijuana Inc.TV (a film company bringing cannabis-related entertainment and news to viewers), Herba Genix, Eco Harmony and numerous other spin-off companies. It would certainly appear that HEMP has an extremely diversified business plan. However, it is difficult to find any information on the success of the company, being that it has no SEC filings and no earnings releases.

 

Speculative Marijuana Stock #3: Cannabis Science Inc

 

CBIS, with a current market cap of around $60 million, has been one of the most commonly traded marijuana stocks among professional traders and (like HEMP) had a strong run in November 2012 before coming back down. CBIS is certainly very much a development-stage company, and its fundamentals are ugly (in its latest 10Q it had only $9,492 in cash, extremely low revenues, and a whopping $84,632,873 in net losses since inception), but that shouldn't stop the stock from being able to run up further in future.

 

It should be very obvious that CBIS is not a company to invest in for the long term based on its business operations and fundamentals. Rather, CBIS, like most marijuana stocks (such as HEMP above), is purely a day-traders' stock that can potentially run up or down very quickly depending on what the latest news is in the marijuana industry.

 

Speculative Marijuana Stock #4: GrowLife

 

PHOT is only partly involved in the marijuana industry. On its company page, we can see that it manufactures LED lights, monitoring and control equipments, and hydroponic equipment. These products do have applications in cultivating cannabis, but cannabis-growers surely account for only a small fraction of customers. Even upon further legalization of marijuana in more states it seems unlikely that PHOT will experience a serious increase in revenue. PHOT also owns the cannabis.org website (currently in construction), which is being planned as an information portal for the medical marijuana industry, although at this stage it's unclear how this website will generate revenue. Despite having only a minor connection to the marijuana industry, PHOT did spike on Friday together with other marijuana stocks, and is still worth watching.

 

In its latest 10Q, for September 30th 2012, PHOT had $161,181 in cash and $1,852,667 in total assets, with total liabilities of $ 1,689,638. Revenue for the three months ended September 30th was $475,870, and there was a net loss for the nine months ended September 30th of $849,707. PHOT therefore does not have strong financials, but at least has achieved some revenue unlike many other marijuana related stocks. Most importantly for its stock price, PHOT's market cap is currently very low (roughly $30 million and fluctuating wildly), and there is plenty of room for this stock to spike further.

 

Speculative Marijuana Stock #5: GreenGro Technologies, Inc

 

GRNH has the lowest market cap of any stock in this article, at around just $15 million. That makes it extremely volatile and easily capable of making big moves. Like PHOT, GRNH sells products that could aid in the growing of cannabis, such as lighting, nutrients, seeds and DIY kits. The GRNH company website strikes me as very amateurish, and there is no information on the financials or revenue of this company (I expect that it is very low, or non-existent). The company twitter feed should also serve as a red flag given that it primarily hypes up the marijuana industry, and seems to try very hard to draw in buyers to GRNH stock. I believe GRNH is very clearly a stock setup to profit off the marijuana industry hype and speculation, rather than to actually run a real business, and that the real value of this company is probably very low. But this stock is still worth watching as it's easily capable of spiking.

 

For More Information On Marijuana Stocks

 

Feel free to message me or leave a comment below if you have any corrections, suggestions or feedback: stockballer.com

Link to comment
Share on other sites

OK, last update for a while as all cannabis stocks are down this morning and therefore it is not nearly as fun reporting the prices....lol. Hope you investors already took some profits as that was a pretty good run.

 

Unlike your typical pump and dump stocks that take a meteoric rise and then dive, I think several of these still have the potential to go much higher because the underlying business is real. They may still fade down for a little while but I still like the prospects here.

 

I read that in this industry, unlike many new markets, the customer base and demand is already in place. The change is simply sending customer money to new legal businesses rather than the illegal dealers.

 

Anyway, as I was telling a fellow investor, I went from almost buying the yacht named Ride the Green Wave to eying the dingy named Shoulda Sold Schooner. Good luck.

 

 

 

 

fyi.....

 

As of 10:20am today, Wednesday, 2/6.

 

Recall that prices change rapidly...

 

Buyer beware!!!!

 

GRNH ..down over 18% today

 

HEMP down over 15% today

 

MJNA down 9%.

 

CBIS moving down too, about 10%.

 

RFMK unchanged

 

GWPRF up 2%

 

XCHC is down 12%

Link to comment
Share on other sites

XCHC X-Change Corp

 

http://finance.yahoo.com/news/xchc-signs-historic-agreement-wolastokwik-134800302.html

 

 

 

XCHC Signs Historic Agreement with WOLASTOKWIK NeGoot-Gook, Maliseet Nation at Tobique of Eastern Canada that Allows Medical Cannabis Hospitals, Laboratories, Clinics, for Cannabinoid Research and Treatments, Open to the World, All in Full Compliance with Law

 

DALLAS, Feb. 13, 2013 /PRNewswire/ -- The X-Change Corporation (NASDAQ OTC: XCHC) (X-Change Corp. or the Company), a U.S. boutique company whose niche is cannabis and hemp based extracts and products that target medical cannabis, cosmeceutical, nutraceutical, and social usage solutions through multiple Phytiva Brand product lines and solutions, is proud to announce it has entered into a historic agreement with WOLASTOKWIK NeGoot-Gook, Maliseet Nation at Tobique (the "Maliseet Nation") of New Brunswick, Canada, to participate in the development and growth of a legal cannabis growing facility, clinical laboratory, manufacturing and production facility, and treatment center (the "Agreement").

The Agreement allows for legal cannabis and hemp-based medical research and treatments with true global significance, as the operations under the Agreement facilitate medical cannabis and hemp research, clinical trials, and treatments, among numerous other opportunities for the parties to the Agreement, for the first time in North America. And these historical groundbreaking operations, including medical treatments, will be open to the citizens of the world in a legal manner. The sovereignty of the Maliseet Nation allows this venture to accomplish its goals of helping patients while being legally compliant.

The Agreement was effectuated by the Company's purchase of the twenty-five percent (25%) stake in a joint venture from Cannabis Science, Inc. (NASDAQ OTC: CBIS). Details of the Company's stock-based asset purchase will be released in a Form 8K to be filed promptly.

X-Change Corp.'s agreement with the Maliseet Nation provides the parties with unprecedented opportunities to develop a model that the Company can replicate around the world from cannabis growth, to clinical research and development, production, and medical treatment of patients with a wide range of conditions believed to be effectively treatable with cannabis extract based formulations. As the parties work to successfully realize the terms of the Agreement, the Company and the other parties will have the opportunity to develop additional clinics, laboratories, production facilities, and hospitals.

It is contemplated by the parties that from working to fulfill the goals of the Agreement will come the development and discovery of medicines and modalities to be pursued for approval with the FDA and other similar governmental bodies.

There are also positive implications with regard to establishing a global network of resources needed to finally solidify a global cannabis and hemp seed-to-treatment model that can be accepted as the industry standard. In pursuit of that goal, the facilities and services in the Agreement will initially target the Canadian market as well as that of the United States with marketing to North American and then international travelers who have a desire to participate in cannabis-based medical treatments with full legal compliance.

Internal estimates calculate that over 30 million people in the United States and over 100 million globally have the potential to be clients and patients over the next five years. Since a wide range of ailments has been targeted, the market potential is in the hundreds of millions of dollars over the next five to ten years.

"The only thing bigger than this opportunity is my smile," stated Robert Kane, President, X-Change Corp. "It is so very important to establish these types of facilities for those who are suffering needlessly. Further, this exciting venture as envisioned by the Agreement allows for the scientific gathering of data and clinical information to support efforts to silence critics and persuade governments with indisputable evidence of the medical value of these facilities and their treatments."

X-Change Corp.'s Phytiva Brand of products will also be marketable through the channels described in the Agreement, promising strong sales growth for these novel and innovative hemp-based skincare and other products.

About The X-Change Corporation

X-Change Corp. is U.S. Boutique Company whose niche is cannabis and hemp based extracts and products that target medical cannabis, cosmeceutical, nutraceutical, and social usage solutions through multiple Phytiva Brand product lines, products, and services. The Company issues a stronger outlook for 2013 based on new Phytiva Brand product lines for the Medical Cannabis Industry as a whole. These new Phytiva product lines will be launched with Cannabis based formulations through Medical Cannabis dispensaries, Cannabis laboratories, and individual legal state or legal foreign grow operations on a jurisdiction by jurisdiction approved basis.

Forward Looking Statements

This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing works such as "anticipate," "seek," intend," "believe," "plan," "estimate," "expect," "project," "plan," or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations regarding the use and development of cannabis-based drugs and products. X-Change Corp. does not undertake any duty nor does it intend to update the results of these forward-looking statements.

X-Change Corp.

President & CEO

Robert Kane

info@phytiva.com

www.phytiva.com

1.866.326.5595

Link to comment
Share on other sites

A friend of mine turned 25K in over 250k listening to Kramer and is subscribed to his news letter this in about 2 years. Doing just what he says even if he could have held longer for more profit he would sell when Kramer said to sell LOL it worked for him. I think once Kramer says to watch something people start scooping it up for a while.

Link to comment
Share on other sites

A friend of mine turned 25K in over 250k listening to Kramer and is subscribed to his news letter this in about 2 years. Doing just what he says even if he could have held longer for more profit he would sell when Kramer said to sell LOL it worked for him. I think once Kramer says to watch something people start scooping it up for a while.

 

He is an entertainer first and foremost. Your friend seems to be an anomaly from the research I have done. It would have been hard not to make money in the last two years in the market but I have a really hard time believing he did this on kramer recs.

Link to comment
Share on other sites

I agree with Mike, Kramer is a wild card and I know lots of people that would love to burn him at the stake. But even a blind squirrel can find a nut once in awhile.

 

On a personal note I am celebrating today. I own 600 shares of GNC and thanks to them blowing out wall street expectations and jumping 3.00 a share today I am finally back on even ground after getting my clock cleaned good on the facebook debacle. Sweet

 

I also bought 100 shares of Tesla at 32 awhile back. I wish I had bought more, they are rocking!

Edited by SFC
Link to comment
Share on other sites

He insists it is listening to Cramer that helps him. He has made a lot of money but it is also doing your own research which he does after hearing his recs. He is also invested in First Solar which is a good one to buy right now it is heading back up. He does not own any marijuana stocks yet

Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...